Javed A, Kanwal U, Gilani SAN, Akhtar F, Shamim R, Abbas N, Bukhari NI. Development of Simple Dissolution Methods for Felodipine and Combined Amlodipine Besylate -Indapamide Extended Release Tablets without Stationary (Felodipine) Basket.
Curr Pharm Des 2022;
28:2010-2021. [PMID:
35619254 DOI:
10.2174/1381612828666220526122615]
[Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/28/2021] [Accepted: 04/07/2022] [Indexed: 11/22/2022]
Abstract
BACKGROUND
The dissolution method for certain drugs needs specialized conditions. Dissolution testing for felodipine extended release (ER) tablets (Plendil® 5mg) and amlodipine-indapamide fixed dose (Natrilam®, 5/1.5 mg) ER tablets require the use of a stationary (felodipine) basket in USP Apparatus II.
OBJECTIVE
The study aimed to develop simple methods for Plendil® and Natrilam® without the use of a felodipine basket.
METHOD
The dissolution profiles obtained from different media and paddle speeds were used to compute miscellaneous dissolution parameters and were compared to those obtained from standard (existing) methods using a felodipine basket.
RESULTS
The f1, f2, and bootstrap f2 (5th % percentile) values for Plendil® were 2.47, 88.17, and 54.62, respectively, while all other dissolution factors revealed similarity between standard and the selected test method with 1% Tween 20 at 50 rpm. For Natrilam®, f1 and f2 and bootstrap f2 were 5.13, 72.92, and 62.67, respectively and all other dissolution parameters were also similar for the standard and selected test method using 0.1N HCl media having 0.38gm/L EDTA with a sinker at 100 rpm. Release of products assumed zero order and Weibull model, respectively.
CONCLUSION
Test dissolution methods for Plendil® and Natrilam® tablets produced equivalent dissolution profiles compared to standard methods with stationary basket USP Apparatus II.
Collapse